Effects of Coenzyme Q10 Supplement on Cardiovascular Risk Factors in Subjects at High Risk of Metabolic Syndrome

NARecruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions

Metabolic SyndromeCardiovascular Diseases

Interventions

DIETARY_SUPPLEMENT

coenzyme Q10

300 mg capsule twice a day

DIETARY_SUPPLEMENT

placebo

300 mg capsule twice a day

Trial Locations (1)

RECRUITING

School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen

All Listed Sponsors

lead

Tian Zezhong

OTHER